Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

By N. Choudhry, H. Stelfox, A. Detsky. Journal of the American Medical Association (JAMA), 2002

639 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update) (2017, background): “Potential conflicts of interest for all panel members in the past 5 years were compiled and distributed before the first conference call and were updated at each subsequent call and in-person meeting.(41) After review and discussion of these disclosures, the panel concluded that individuals with pot”
Scientific evidence underlying the ACC/AHA clinical practice guidelines. (2009, background): “Recommendations based only on expert opinion may be prone to conflicts of interest because, just as clinical trialists have conflicts of interests, expert clinicians are also those who are likely to receive honoraria, speakers bureau, consulting fees, or research support from industry.(73,74) It is ”
Clinical Practice Guideline (2014, positive): “After review and discussion of these disclosures, 42 the panel concluded that individuals with potential conflicts could remain on the panel if they (1) reminded the panel of potential conflicts before any related discussion, (2) recused themselves from a related discussion if asked by the panel,…”